KR100785017B1 - 혈액으로부터 핵산을 증폭하는 방법 - Google Patents
혈액으로부터 핵산을 증폭하는 방법 Download PDFInfo
- Publication number
- KR100785017B1 KR100785017B1 KR1020060050478A KR20060050478A KR100785017B1 KR 100785017 B1 KR100785017 B1 KR 100785017B1 KR 1020060050478 A KR1020060050478 A KR 1020060050478A KR 20060050478 A KR20060050478 A KR 20060050478A KR 100785017 B1 KR100785017 B1 KR 100785017B1
- Authority
- KR
- South Korea
- Prior art keywords
- blood
- sample
- pcr
- voltage
- electrodialysis
- Prior art date
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 95
- 239000008280 blood Substances 0.000 title claims abstract description 95
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 19
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 19
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims description 36
- 238000000909 electrodialysis Methods 0.000 claims abstract description 36
- 238000005868 electrolysis reaction Methods 0.000 claims abstract description 28
- 238000006243 chemical reaction Methods 0.000 claims description 24
- 239000012528 membrane Substances 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 19
- 238000010790 dilution Methods 0.000 claims description 12
- 239000012895 dilution Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 7
- 239000008151 electrolyte solution Substances 0.000 claims description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 63
- 241000588724 Escherichia coli Species 0.000 description 21
- 238000010586 diagram Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 9
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 150000002500 ions Chemical class 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 239000003014 ion exchange membrane Substances 0.000 description 4
- 238000000137 annealing Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 238000000751 protein extraction Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 229920000298 Cellophane Polymers 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002683 reaction inhibitor Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
- B01D61/422—Electrodialysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/20—Specific permeability or cut-off range
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/60—Detection means characterised by use of a special device
- C12Q2565/629—Detection means characterised by use of a special device being a microfluidic device
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Water Supply & Treatment (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
Description
조성(㎕) | 1 | 2 | 3 | 4 | 5 | 6 |
1x버퍼 | 5 | 5 | 5 | 5 | 5 | 5 |
dNTP | 1 | 1 | 1 | 1 | 1 | 1 |
포워드프라이머 | 1 | 1 | 1 | 1 | 1 | 1 |
리버스 프라이머 | 1 | 1 | 1 | 1 | 1 | 1 |
BSA | 5 | 5 | 5 | 5 | 5 | 5 |
Taq | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
증류수 | 35.25 | 35 | 34 | 33 | 30.5 | 20.5 |
대장균 DNA | 1 | 1 | 1 | 1 | 1 | 1 |
시료 | 0.25 | 0.5 | 1.5 | 2.5 | 5 | 15 |
총 부피 | 50 | 50 | 50 | 50 | 50 | 50 |
총부피에대한 혈액 함량(%) | 0.5 | 1 | 3 | 5 | 10 | 30 |
조성(㎕) | 1 | 2 | 3 | 4 |
1x버퍼 | 5 | 5 | 5 | 5 |
dNTP | 1 | 1 | 1 | 1 |
포워드프라이머 | 1 | 1 | 1 | 1 |
리버스 프라이머 | 1 | 1 | 1 | 1 |
BSA | 5 | 5 | 5 | 5 |
Taq | 0.5 | 0.5 | 0.5 | 0.5 |
증류수 | 35 | 34 | 31.5 | 26.5 |
시료 | 1.5 | 2.5 | 5 | 10 |
총 부피 | 50 | 50 | 50 | 50 |
총부피에대한 혈액 함량(%) | 3 | 5 | 10 | 20 |
Claims (16)
- 혈액을 포함하는 시료를 전기투석하여 상기 시료의 이온 강도를 낮추는 단계; 및상기 전기투석된 혈액 시료를 주형으로 하여 PCR을 수행하는 단계를 포함하는, 혈액으로부터 핵산을 증폭하는 방법으로서,상기 전기투석하는 단계는 하나 이상의 벽에 분자량 컷-오프 막을 포함하는 희석 구획에 혈액을 주입하는 단계; 및상기 막 사이에 전압을 인가하여 이온 물질을 상기 희석 구획으로부터 농축 구획으로 이동시키는 단계를 포함하는 것인 방법.
- 삭제
- 제1항에 있어서, 상기 분자량 컷-오프 막은 1kDa 내지 500 kDa의 분자량 컷-오프를 갖는 것인 방법.
- 제1항에 있어서, 상기 전압은 직류인 방법.
- 제1항에 있어서, 상기 희석 구획은 2개의 마주보는 벽면이 분자량 컷-오프 막으로 구성되어 있는 것인 방법.
- 제1항에 있어서, 상기 전압은 10 V 내지 200 V인 방법.
- 삭제
- 제1항에 있어서, 상기 PCR은 상기 전기 투석된 혈액 시료를 반응액의 0.1% 내지 30%를 주형으로 하여 수행되는 것인 방법.
- 제1항에 있어서, 상기 전기투석하는 단계 전에 상기 혈액을 포함하는 시료를 전기분해하는 단계 또는 상기 전기투석하는 단계 후에 상기 전기투석된 혈액을 전기분해하는 단계를 더 포함하는 방법으로서,상기 전기분해는 이온투과성 막에 의하여 분리된 캐소드 챔버와 애노드 챔버에 각 전해질 용액을 첨가하고 전압을 인가하여 이루어지는 것으로서, 상기 캐소드 챔버에는 상기 혈액을 포함하는 시료 또는 상기 전기투석된 혈액이 포함되어 있는 것인 방법.
- 삭제
- 제9항에 있어서, 상기 전압은 1 V 내지 100 V인 방법.
- 삭제
- 혈액을 포함하는 시료를 전기분해하는 단계; 및상기 전기분해된 혈액 시료를 주형으로 하여 PCR을 수행하는 단계를 포함하는, 혈액으로부터 핵산을 증폭하는 방법으로서,상기 전기분해는 이온투과성 막에 의하여 분리된 캐소드 챔버와 애노드 챔버에 각 전해질 용액을 첨가하고 전압을 인가하여 이루어지는 것으로서, 상기 캐소드 챔버에는 상기 혈액을 포함하는 시료 또는 상기 전기투석된 혈액이 포함되어 있는 것인 방법.
- 삭제
- 제13항에 있어서, 상기 전압은 1 V 내지 100 V인 방법.
- 삭제
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060050478A KR100785017B1 (ko) | 2006-06-05 | 2006-06-05 | 혈액으로부터 핵산을 증폭하는 방법 |
US11/746,722 US8715965B2 (en) | 2006-06-05 | 2007-05-10 | Method of amplifying nucleic acid from blood |
EP07109428A EP1865075B1 (en) | 2006-06-05 | 2007-06-01 | A method of amplifying nucleic acid from blood |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060050478A KR100785017B1 (ko) | 2006-06-05 | 2006-06-05 | 혈액으로부터 핵산을 증폭하는 방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070116438A KR20070116438A (ko) | 2007-12-10 |
KR100785017B1 true KR100785017B1 (ko) | 2007-12-12 |
Family
ID=38319320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060050478A KR100785017B1 (ko) | 2006-06-05 | 2006-06-05 | 혈액으로부터 핵산을 증폭하는 방법 |
Country Status (3)
Country | Link |
---|---|
US (1) | US8715965B2 (ko) |
EP (1) | EP1865075B1 (ko) |
KR (1) | KR100785017B1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100790889B1 (ko) | 2006-09-26 | 2008-01-02 | 삼성전자주식회사 | 전기 투석 장치 및 이를 이용한 전기 투석 방법 |
JP6217637B2 (ja) * | 2012-07-25 | 2017-10-25 | ソニー株式会社 | 核酸増幅反応用試料の調製方法及び核酸増幅反応用試料の調製装置 |
US9758773B2 (en) | 2014-02-14 | 2017-09-12 | Agilent Technologies, Inc. | Thermostable type-A DNA polymerase mutant with increased resistance to inhibitors in blood |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR900016463A (ko) * | 1989-04-17 | 1990-11-13 | 제이. 제프리 헐리 | 완전혈액 또는 pbmc 부분으로부터 핵산을 추출하여 증폭시키며 검사하는 방법 |
KR100601972B1 (ko) | 2004-11-03 | 2006-07-18 | 삼성전자주식회사 | 레이저와 비드를 이용한 상 분리에 의한 핵산의 정제 장치및 방법 |
KR100601974B1 (ko) | 2004-11-25 | 2006-07-18 | 삼성전자주식회사 | 비드의 상이한 레이저 흡수에 의한 핵산의 정제 장치 및방법 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4306556A (en) | 1980-02-07 | 1981-12-22 | Rensselaer Polytechnic Institute | Method and apparatus for storing and preparing cryopreserved blood |
US4407942A (en) | 1981-01-29 | 1983-10-04 | Atomic Energy Of Canada Limited | Fluorescent detection of DNA damage |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5437774A (en) | 1993-12-30 | 1995-08-01 | Zymogenetics, Inc. | High molecular weight electrodialysis |
JP3541963B2 (ja) | 1994-03-09 | 2004-07-14 | 豊田工機株式会社 | 加工装置 |
US5935825A (en) | 1994-11-18 | 1999-08-10 | Shimadzu Corporation | Process and reagent for amplifying nucleic acid sequences |
JP3193295B2 (ja) * | 1995-07-07 | 2001-07-30 | 株式会社日本トリム | 透析装置 |
EP1075548A1 (de) * | 1998-05-04 | 2001-02-14 | Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.V. | Elektrische, integrierte nucleinsäureisolierung, -reinigung und -detektion |
US6284117B1 (en) * | 1999-12-22 | 2001-09-04 | Nanogen, Inc. | Apparatus and method for removing small molecules and ions from low volume biological samples |
EP1730276B8 (en) | 2004-02-26 | 2010-07-21 | DELTA Dansk Elektronik, Lys og Akustik | Method, chip, device and system for extraction of biological materials |
US7488596B2 (en) | 2004-12-17 | 2009-02-10 | Samsung Electronics Co., Ltd. | Microfluidic device comprising electrolysis device for cell lysis and method for electrochemically lysing cells using the same |
-
2006
- 2006-06-05 KR KR1020060050478A patent/KR100785017B1/ko active IP Right Grant
-
2007
- 2007-05-10 US US11/746,722 patent/US8715965B2/en active Active
- 2007-06-01 EP EP07109428A patent/EP1865075B1/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR900016463A (ko) * | 1989-04-17 | 1990-11-13 | 제이. 제프리 헐리 | 완전혈액 또는 pbmc 부분으로부터 핵산을 추출하여 증폭시키며 검사하는 방법 |
KR100601972B1 (ko) | 2004-11-03 | 2006-07-18 | 삼성전자주식회사 | 레이저와 비드를 이용한 상 분리에 의한 핵산의 정제 장치및 방법 |
KR100601974B1 (ko) | 2004-11-25 | 2006-07-18 | 삼성전자주식회사 | 비드의 상이한 레이저 흡수에 의한 핵산의 정제 장치 및방법 |
Also Published As
Publication number | Publication date |
---|---|
EP1865075B1 (en) | 2012-09-12 |
US8715965B2 (en) | 2014-05-06 |
KR20070116438A (ko) | 2007-12-10 |
EP1865075A1 (en) | 2007-12-12 |
US20070281307A1 (en) | 2007-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4906337B2 (ja) | 細胞またはウイルス溶解用の電気分解素子を備える微小流体素子、およびそれを用いた細胞またはウイルスの溶解方法 | |
Qu et al. | Ultrafiltration (UF) membrane fouling caused by cyanobateria: Fouling effects of cells and extracellular organics matter (EOM) | |
US20060037860A1 (en) | Small separation apparatus | |
JP2008532753A (ja) | 電気濾過方法 | |
KR100785017B1 (ko) | 혈액으로부터 핵산을 증폭하는 방법 | |
KR100624471B1 (ko) | 세포 분해용 전기분해 장치를 포함하는 미세유동장치 및그를 이용하여 전기화학적으로 용해하는 방법 | |
US4426323A (en) | Selected recovery of proteins from fermentation broths | |
US4146455A (en) | Process for treating whey | |
Majewska-Nowak | Treatment of organic dye solutions by electrodialysis | |
DE69733755T2 (de) | Elektrode-einfang von nukleinsäuren | |
US10391456B2 (en) | Electrolyte chemistry and improved stack performance in high brine concentration electrodialysis | |
US4180451A (en) | Apparatus for treating whey | |
Aider et al. | Potential of continuous electrophoresis without and with porous membranes (CEPM) in the bio-food industry | |
US9909164B2 (en) | Method for preparing sample for nucleic acid amplification reaction and preparation device of sample for nucleic acid amplification reaction | |
KR20090058221A (ko) | 시료 중의 세포 집단으로부터 죽은 세포를 선택적으로파쇄하는 방법 | |
CN107058515A (zh) | 一种微囊藻毒素降解菌的快速高效筛选方法 | |
CN112892220A (zh) | 一种高效的活性蛋白分离方法与装置 | |
AU2017344755B2 (en) | Electrophoresis device | |
KR100624447B1 (ko) | 은 나노 입자를 이용한 핵산의 정제 방법 | |
US20230127490A1 (en) | Electrophoresis device | |
KR101985432B1 (ko) | 핵산 추출을 위한 소변 시료 전처리 방법 | |
RU2171035C2 (ru) | Способ получения кормовой добавки из сока растений | |
JPH02258032A (ja) | 脱塩方法 | |
CN112979746A (zh) | 一种蛋清中活性蛋白同步分离的方法与装置 | |
CN104415661A (zh) | 一种生物大分子的分离技术及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121115 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20131122 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20141119 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20151116 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20161118 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20171120 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20181119 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20191119 Year of fee payment: 13 |